Pinion Investment Advisors LLC Makes New Investment in Axon Enterprise, Inc. (NASDAQ:AXON)

Pinion Investment Advisors LLC bought a new stake in Axon Enterprise, Inc. (NASDAQ:AXON) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund bought 630 shares of the biotechnology company’s stock, valued at approximately $374,000.

A number of other institutional investors have also modified their holdings of the stock. Charles Schwab Investment Management Inc. grew its position in Axon Enterprise by 4.6% in the 4th quarter. Charles Schwab Investment Management Inc. now owns 449,507 shares of the biotechnology company’s stock valued at $267,151,000 after buying an additional 19,818 shares during the last quarter. State of Michigan Retirement System boosted its holdings in shares of Axon Enterprise by 0.5% in the fourth quarter. State of Michigan Retirement System now owns 19,700 shares of the biotechnology company’s stock valued at $11,708,000 after acquiring an additional 100 shares in the last quarter. Bedel Financial Consulting Inc. acquired a new position in shares of Axon Enterprise during the fourth quarter worth about $178,000. Meridian Wealth Management LLC raised its holdings in Axon Enterprise by 10.9% during the fourth quarter. Meridian Wealth Management LLC now owns 826 shares of the biotechnology company’s stock worth $491,000 after purchasing an additional 81 shares in the last quarter. Finally, SBI Securities Co. Ltd. purchased a new position in Axon Enterprise during the fourth quarter worth about $817,000. Institutional investors and hedge funds own 79.08% of the company’s stock.

Insider Buying and Selling at Axon Enterprise

In other news, Director Julie A. Cullivan sold 1,261 shares of the company’s stock in a transaction on Wednesday, December 4th. The stock was sold at an average price of $682.06, for a total value of $860,077.66. Following the sale, the director now directly owns 2,392 shares in the company, valued at $1,631,487.52. This represents a 34.52 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, President Joshua Isner sold 1,291 shares of Axon Enterprise stock in a transaction dated Tuesday, December 17th. The stock was sold at an average price of $642.43, for a total value of $829,377.13. Following the sale, the president now owns 181,892 shares of the company’s stock, valued at approximately $116,852,877.56. This represents a 0.70 % decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 6,407 shares of company stock worth $4,122,925. 6.10% of the stock is owned by insiders.

Axon Enterprise Stock Down 0.5 %

AXON stock opened at $525.75 on Tuesday. The company has a debt-to-equity ratio of 0.32, a current ratio of 2.96 and a quick ratio of 2.63. Axon Enterprise, Inc. has a 12 month low of $273.52 and a 12 month high of $715.99. The firm has a market capitalization of $40.09 billion, a PE ratio of 135.85, a P/E/G ratio of 5.17 and a beta of 1.05. The company’s 50 day simple moving average is $607.58 and its 200-day simple moving average is $526.43.

Analyst Upgrades and Downgrades

Several equities analysts have issued reports on AXON shares. TD Cowen began coverage on Axon Enterprise in a research report on Wednesday, January 8th. They set a “buy” rating and a $700.00 target price on the stock. Northland Securities upped their price objective on Axon Enterprise from $365.00 to $550.00 and gave the stock an “outperform” rating in a report on Monday, November 11th. Needham & Company LLC reiterated a “buy” rating and issued a $600.00 price objective on shares of Axon Enterprise in a research report on Wednesday, February 26th. Morgan Stanley upgraded shares of Axon Enterprise from an “equal weight” rating to an “overweight” rating and boosted their target price for the stock from $500.00 to $700.00 in a research report on Tuesday, December 3rd. Finally, The Goldman Sachs Group increased their price target on shares of Axon Enterprise from $500.00 to $700.00 and gave the company a “buy” rating in a report on Monday, January 27th. Three analysts have rated the stock with a hold rating and thirteen have given a buy rating to the company’s stock. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus price target of $587.38.

Axon Enterprise Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.